Table 7.
Criteria | Simadibrata DM, 2020 | Lagunas-rangel FA, 2020 | Ghahramani, 2020 | Li X, 2020 | Ulloque-badaracco, 2021 | Present meta-analysis | |
---|---|---|---|---|---|---|---|
No. of studies (severity) | 38 | 5 | 22 | 13 | 36 | 24 | |
No. of subjects (severity) | 5,699 | 828 | 3,396 | 1,579 | 8,732 | 4,080 | |
No. of studies (mortality) | 38 | — | — | — | 28 | 15 | |
No. of subjects (mortality) | 6,033 | — | — | — | 6,790 | 4,071 | |
Recommended guidelines for prognostic meta-analysis reporting | Pooled sensitivity | × | × | × | √ | × | √ |
Pooled sensitivity | × | × | × | √ | × | √ | |
Summary area under the curve | × | × | × | √ | × | √ | |
Diagnostic odds ratio | × | × | × | √ | × | √ | |
Methodological quality (QUIPS) | × | × | × | × | × | √ | |
GRADE criteria | × | × | × | × | × | √ | |
Publication bias | √ | × | × | √ | √ | √ | |
Analysis used pooled sensitivity, pooled specificity, summary area under the curve, and diagnostic odds ratio | × Standard mean difference. |
× Standard mean difference. |
× Pooled weighted mean difference |
√ Pooled sensitivity, pooled specificity, Summary Area under the curve, Diagnostic odds ratio. |
× Log odds ratio |
√ Pooled sensitivity, pooled specificity, Summary Area under the curve, Diagnostic odds ratio. |